Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Information for Advertisers
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Editor Picks
    • Blogging Stroke
    • AHA/ASA Guidelines and Statements
    • ISC and Nursing Symposium Abstracts
    • Progress and Innovation Award Recipients
    • Acknowledgment of Reviewers
    • Stroke in Women
    • Outstanding Reviewers 2017
  • Resources
    • Online Submission/Peer Review
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • → Tips for Submission
    • → Links and Forms
    • → Revised Manuscripts
    • Costs to Authors
    • Journal Policies
    • Wolters Kluwer Author Services
    • Early Career Resources
    • Stroke CME
    • Webinar Series
    • Permissions and Rights Q&A
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Stroke

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Information for Advertisers
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Editor Picks
    • Blogging Stroke
    • AHA/ASA Guidelines and Statements
    • ISC and Nursing Symposium Abstracts
    • Progress and Innovation Award Recipients
    • Acknowledgment of Reviewers
    • Stroke in Women
    • Outstanding Reviewers 2017
  • Resources
    • Online Submission/Peer Review
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • → Tips for Submission
    • → Links and Forms
    • → Revised Manuscripts
    • Costs to Authors
    • Journal Policies
    • Wolters Kluwer Author Services
    • Early Career Resources
    • Stroke CME
    • Webinar Series
    • Permissions and Rights Q&A
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial Comment

Reversible Cerebral Vasoconstriction Syndrome and Intracranial Hemorrhage

Some Answers, Many Questions

David J. Werring
Download PDF
https://doi.org/10.1161/STROKEAHA.110.593905
Stroke. 2010;41:2455-2456
Originally published October 25, 2010
David J. Werring
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Supplemental Materials
  • Info & Metrics
Loading
  • acute stroke
  • angiography
  • cerebral vasoconstriction
  • headaches
  • intracerebral hemorrhage

Reversible cerebral vasoconstriction syndrome (RCVS) is a fairly recently described constellation of clinical and radiological features: sudden, severe (“thunderclap”) headache; transient, multifocal, segmental vasoconstriction of cerebral arteries lasting several weeks to months; and focal neurological symptoms, sometimes with stroke. The features of what is now called RCVS have been repeatedly recognized, especially since an influential early report by Drs Call and Fleming et al1 published in 1988. A similar syndrome has attracted many different names, depending on whether patients present to specialists in headache, obstetrics, or neurology. These include thunderclap headache with vasospasm, migrainous vasospasm (or “crash” migraine), migrainous angiitis, drug-induced angiitis, postpartum angiopathy, and benign angiopathy of the central nervous system. The label RCVS is an attempt to unify these various descriptions of a distinct clinico-radiological pattern. Nevertheless, there remains uncertainty about the status of RCVS as a true “disease,” which can generally be defined, with progressively less certainty, according to (1) a defined cause; (2) the underlying mechanism (pathophysiology); or (3) a pattern of symptoms and investigation findings (syndrome). As knowledge evolves, some syndromes become more clearly defined by cause or mechanisms, whereas others may not endure. RCVS is a syndrome still in the process of being defined; our understanding and knowledge are increasing as neuroimaging methods improve and more cases are discovered. However, it seems likely that there are many causes (or triggers) for RCVS, and probably more than one underlying pathophysiological mechanism causing abnormal vascular tone. Multiple etiologies for RCVS are suggested by the many and varied associations, including sympathomimetic, serotonergic, or other drugs, pregnancy, and the puerperium,2 although no obvious cause can be found in approximately one-half of cases.

It has increasingly been reported that intracranial hemorrhage, especially cortical subarachnoid bleeding, can accompany RCVS.3–7 In this issue of Stroke, Ducros et al8 from the Lariboisiere hospital report on a series of 89 consecutive patients with RCVS diagnosed in their service (with specialist expertise in both headache and stroke), of whom 30 (34%) had at least 1 type of intracranial hemorrhage, compared to only 5 (6%) with cerebral infarction (which tended to occur later than hemorrhage). This large series (for a fairly rare condition) allowed the authors not only to describe the patterns of bleeding but also to investigate the risk factors for hemorrhage in RCVS. The authors found that cortical subarachnoid hemorrhage was the most common pattern, affecting 27 of the 40 cases of hemorrhage; women and those with migraine were at highest risk. Although recruitment in such a specialist referral center is not free of bias, and the diagnostic work-up was not standardized, the findings do suggest that intracranial hemorrhage in RCVS is much more common than previously thought and further challenges the concept of RCVS as a benign self-limiting syndrome.2

What causes the high rate of hemorrhagic complications in RCVS? The authors suggest that the intracranial bleeding is a result of the vasospasm, rather than the trigger. However, the causal direction of the relationship is difficult to prove. This is important because the most commonly understood reason for vasospasm or vasoconstriction in stroke is as a result of subarachnoid hemorrhage (usually, but not always, aneurysmal).9 A clinical presentation indistinguishable from RCVS has been documented in the context of aneurysmal subarachnoid hemorrhage.10 One way to strengthen the argument that vasospasm is a cause of bleeding is to show that the bleeding complications occur after the documentation of vasospasm. However, in the present study, vasospasm was concomitant with intracerebral hemorrhage in 15, and after hemorrhage in 14 patients; the mean time of diagnosis of intracranial hemorrhage was 2.2 days from headache onset and the mean time to diagnosis of vasoconstriction was 6.6 days. The authors argue that the pattern of subarachnoid blood in their cohort (unilateral or bilateral focal cortical) is unlikely to cause multifocal vasospasm. Although this may be true, it also remains unclear how multifocal vasospasm could cause usually rather focal subarachnoid hemorrhage. Speculated mechanisms include reperfusion injury attributable to vasodilatation after severe vasoconstriction or as a consequence of hypertension and disturbed autoregulation (as may occur in another poorly understood syndrome that overlaps with RCVS, posterior reversible encephalopathy syndrome).

So, on the basis of current understanding, what is the value of a diagnosis of RCVS to practicing stroke physicians, and what should be the impact of the increasingly recognized association with intracranial hemorrhage? A diagnosis of RCVS could help clinicians if it could usefully guide treatment or refine prognosis. There is currently no treatment shown to improve outcome in RCVS. It may well be that therapy needs to be tailored to the underlying causes or mechanisms, although current approaches focus on the shared common factor of vasospasm, which logically might reduce the main complications of infarction and hemorrhage. Because of the similarities with postsubarachnoid hemorrhage-related vasospasm, calcium channel blockers are used in some centers;11 high-dose glucocorticoids are sometimes recommended12 because of radiological similarities with vasculitic disorders and experimental evidence that glucocorticoids reduce vasoconstriction. Other reports emphasize the value of supportive care and careful observation.13 We will only know whether any treatments are helpful by conducting randomized controlled trials, which will require clearer diagnostic criteria to allow appropriate patient selection. Challenges here are the heterogeneity and relative rarity of RCVS, and the requirement to demonstrate that vasoconstriction has resolved after 1 or 2 months, at which time the most useful window for intervention may have passed. This can only be resolved by reliably predicting a diagnosis of RCVS without waiting for reversibility to be proven, which currently is not possible.

Finally, with regard to prognosis, RCVS has been considered a useful label on account of the generally benign clinical outcome, in parallel with resolution of vasospasm. The present study has clearly shown that the prognosis is often not benign because cerebral hemorrhage and infarction may occur, with a significant minority unable to work because of persistent deficits at 6 months. Patients therefore cannot be reassured that RCVS is always benign and will wish to be offered effective treatment. However, before treatment for RCVS can be confidently recommended, trials targeting those at highest risk for poor outcome with rational therapeutic approaches are needed; however, such studies must await a clearer understanding of the underlying mechanisms and prognostic indicators.

Therefore, the true value of RCVS as a diagnostic entity in the clinic remains uncertain, because it cannot yet reliably guide treatment or prognosis. The present study, nevertheless, is an important contribution to the field. It has increased our understanding of the association with intracranial hemorrhage and the range of clinical outcomes, and it has begun to unravel the clinical and radiological predictors of hemorrhage. However, the article raises many important questions and should stimulate further work, ideally collaboratively at multiple centers to increase study power and generalizability, on this fascinating and enigmatic clinical syndrome.

Acknowledgments

Sources of Funding

David Werring is supported by a Department of Health and Higher Educational and Funding Council for England Clinical Senior Lectureship Award. This work was undertaken at UCLH/UCL, which received a proportion of funding from the UK Department of Health’s National Institute for Health Research Biomedical Research Centers funding scheme (UCLH/UCL Comprehensive Biomedical Research Trust).

Disclosures

None.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. ↵
    Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988; 19: 1159–1170.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007; 146: 34–44.
    OpenUrlCrossRefPubMed
  3. ↵
    Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007; 130 (Pt 12): 3091–3101.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Edlow BL, Kasner SE, Hurst RW, Weigele JB, Levine JM. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage. Neurocrit Care. 2007; 7: 203–210.
    OpenUrlCrossRefPubMed
  5. ↵
    Hantson P, Forget P. Reversible cerebral vasospasm, multilobular intracerebral hemorrhages, and nonaneurysmal subarachnoid hemorrhage: review of possible interrelationships. Curr Pain Headache Rep. 2010; 14: 228–232.
    OpenUrlCrossRefPubMed
  6. ↵
    Moustafa RR, Allen CM, Baron JC. Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases. J Neurol Neurosurg Psychiatry. 2008; 79: 602–605.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Santos E, Zhang Y, Wilkins A, Renowden S, Scolding N. Reversible cerebral vasoconstriction syndrome presenting with haemorrhage. J Neurol Sci. 2009; 276: 189–192.
    OpenUrlCrossRefPubMed
  8. ↵
    Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser M-G. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010; 41: 2505–2511.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Jung JY, Kim YB, Lee JW, Huh SK, Lee KC. Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases. J Clin Neurosci. 2006; 13: 1011–1017.
    OpenUrlCrossRefPubMed
  10. ↵
    Forget P, Goffette P, van de Wyngaert F, Raftopoulos C, Hantson P. Possible overlap between reversible cerebral vasoconstriction syndrome and symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Headache Pain. 2009; 10: 299–302.
    OpenUrlCrossRefPubMed
  11. ↵
    Dodick DW. Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): the role of calcium antagonists. Cephalalgia. 2003; 23: 163–165.
    OpenUrlFREE Full Text
  12. ↵
    Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum. 2002; 47: 662–669.
    OpenUrlCrossRefPubMed
  13. ↵
    Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care. 2005; 3: 91–97.
    OpenUrlCrossRefPubMed
View Abstract

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Back to top
Previous ArticleNext Article

This Issue

Stroke
November 2010, Volume 41, Issue 11
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Supplemental Materials
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Reversible Cerebral Vasoconstriction Syndrome and Intracranial Hemorrhage
    David J. Werring
    Stroke. 2010;41:2455-2456, originally published October 25, 2010
    https://doi.org/10.1161/STROKEAHA.110.593905

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Stroke.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Reversible Cerebral Vasoconstriction Syndrome and Intracranial Hemorrhage
    (Your Name) has sent you a message from Stroke
    (Your Name) thought you would like to see the Stroke web site.
  • Share on Social Media
    Reversible Cerebral Vasoconstriction Syndrome and Intracranial Hemorrhage
    David J. Werring
    Stroke. 2010;41:2455-2456, originally published October 25, 2010
    https://doi.org/10.1161/STROKEAHA.110.593905
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Epidemiology, Lifestyle, and Prevention
    • Epidemiology
  • Imaging and Diagnostic Testing
    • Angiography
  • Stroke
    • Intracranial Hemorrhage
    • Ischemic Stroke

Stroke

  • About Stroke
  • Instructions for Authors
  • Stroke CME
  • Guidelines and Statements
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 5th Avenue
Suite 1020
Waltham, MA 02451
email: stroke@strokeahajournal.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured